The Federal Reserve raised its target of the federal-funds rate, the interest rate banks charge each other for overnight loans, by a quarter point to a range of 0.75% to 1%, and thats great news for Warren Buffetts Berkshire Hathaway (BRK.B) and its shareholders. As a bondholder, owner of insurance companies and an investor in big banks, Berkshire profits from rising interest rates in a number....More>>>
By Emmanuel Enemchukwu with Hien X. T. Nguyen, Chenxi Liu, and Elizabeth Ren
Typical of REITs, the most compelling investment thesis for a Healthcare REIT like Medical Property Trust (MPW) has usually been the generous dividend payout. The generosity of its dividends not taken for granted, our valuation of MPW makes a case for underpricing. We are convinced that $17.20 per share – at....More>>>
D.A. Davidson & CO. boosted its position in shares of Praxair (NYSE:PX) by 78.0% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 5,321 shares of the basic materials company’s stock after acquiring an additional 2,332 shares during the quarter. D.A. Davidson & CO.’s holdings in Praxair were worth $768,000 at the end of the....More>>>
I went "whole hog" on a trade in my monthly newsletters, investing in one particular country over the last month. I'm talking about Japan. You NEED to be in this trade. Let me briefly explain why… About a month ago, I recommended Japan in my True Wealth Systems newsletter as my top idea. Not long afterward, I followed that up with a different Japan play,....More>>>
Biotech stocks have climbed steadily higher over the past few weeks. Still, the iShares Nasdaq Biotechnology ETF (IBB) has remained range bound between $240 and $290 for much of 2016.
So with major stock indices hitting new record highs, can biotech stocks break free? Perhaps, says Michael Yee, the industry analyst for RBC Capital Markets. But first, the market wants the political rhetoric....More>>>